New drug duo takes on advanced ovarian cancer in early trial
NCT ID NCT07593092
First seen May 19, 2026 · Last updated May 23, 2026 · Updated 1 time
Summary
This early-phase trial tests whether two experimental drugs, XmAb541 and XmAb808, are safe and tolerable when given together to people with advanced ovarian cancer. The study aims to find the best dose and see if the combination can shrink tumors. About 90 adults with a specific type of ovarian cancer will participate.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Xencor Investigative Site
Detroit, Michigan, 48201, United States
-
Xencor Investigative Site
Omaha, Nebraska, 68198, United States
-
Xencor Investigative Site
Lake Success, New York, 11042, United States
-
Xencor Investigative Site
New York, New York, 10029, United States
-
Xencor Investigative Site
The Bronx, New York, 10461, United States
-
Xencor Investigative Site
Columbus, Ohio, 43210, United States
-
Xencor Investigative Site
Oklahoma City, Oklahoma, 73104, United States
-
Xencor Investigative Site
Fort Worth, Texas, 76104, United States
-
Xencor Investigative Site
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.